금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
US Stock Market Today: S&P 500 Futures Slip As Sticky Inflation Keeps Fed Cautious
The Morning Bull - US Market Morning Update Monday, Jun, 29 2026 US stock futures are pointing lower...
ECB’s Kazāks: The possibility of negative scenarios has fallen massively
European Central Bank (ECB) Governing Council member Mārtiņš Kazāks said during the European trading...
H.B. Fuller stock slides after Q2 earnings beat; volume outlook disappoints
3 Reasons to Avoid ACI and 1 Stock to Buy Instead
Over the past six months, Albertsons’s stock price fell to $14.12. Shareholders have lost 18.9% of their capital, which is disappointing considering the S&P 500 has climbed by 6.3%. This might have in ...
Traders discount a higher bid coming in on Caesars Entertainment
First Trust International Developed Capital Strength ETF declares quarterly distribution of $0.4455
Will the Vanguard S&P 500 ETF Invest in SpaceX Stock? It's Complicated.
SpaceX could be coming to your S&P 500 ETF -- eventually.
Healthcare and data center REITs dominate real estate growth rankings
3 Reasons to Avoid PII and 1 Stock to Buy Instead
Polaris has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7.3% to $71.06 per share while the index has gained 6.3%.
How To Validate Stock Market Ideas With The IBD Stock Checklist
Stock market leader Marvell Technology gets a lot of green in the IBD Stock Checklist due to strong fundamentals and price performance.
Update: Equity Markets Mixed Intraday as Apple Falls, Micron Rallies
(Updates with latest market prices and developments.) US benchmark equity indexes were mixed intr
ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?
ICU Medical has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $142.98. The stock also fell short of the S&P 500’s 6.3% gain during that period.
Palantir's selloff continues, marking the seventh straight session of declines
Record-setting healthcare M&A activity to extend through H2: PwC